Literature DB >> 28831236

Prothrombin fragment F1+2 in plasma and urine during total hip arthroplasty.

Pål O Borgen1, Olav Reikeras2.   

Abstract

OBJECTIVE: To study the time course and correlation of prothrombin fragment (F1 + 2) in plasma and urine during THA.
METHOD: F1 + 2 concentrations were recorded at four time-points during THA.
RESULTS: F1 + 2 increased during surgery. In contrast to urine, plasma F1 + 2 was temporarily reduced the first postoperative day. At day six, plasma F1 + 2 was significantly elevated indicating on-going thrombin activation, while urine F1 + 2 was normalized.
CONCLUSION: The response in coagulation to operative trauma can be recorded with F1 + 2 both in plasma and urine. We were not able to demonstrate any correlation of F1 + 2 in plasma and urine later in the postoperative period.

Entities:  

Keywords:  Biomarkers; Prophylaxis; Thrombosis; Total hip arthroplasty

Year:  2017        PMID: 28831236      PMCID: PMC5555093          DOI: 10.1016/j.jor.2017.08.001

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  16 in total

1.  Identification of a prothrombin derivative in human urine.

Authors:  A Bezeaud; D L Aronson; D Menache; M C Guillin
Journal:  Thromb Res       Date:  1978-09       Impact factor: 3.944

2.  Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Yngve Falck-Ytter; Charles W Francis; Norman A Johanson; Catherine Curley; Ola E Dahl; Sam Schulman; Thomas L Ortel; Stephen G Pauker; Clifford W Colwell
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty.

Authors:  Lars C Borris; Morten Breindahl; Camilla Ryge; Helle M Sommer; Michael R Lassen
Journal:  Thromb Res       Date:  2007-06-27       Impact factor: 3.944

Review 4.  Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

Authors:  R D Hull; G F Pineo; P D Stein; A F Mah; S M MacIsaac; O E Dahl; W A Ghali; M S Butcher; R F Brant; D Bergqvist; K Hamulyák; C W Francis; V J Marder; G E Raskob
Journal:  Arch Intern Med       Date:  2001-09-10

5.  Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.

Authors:  E Cofrancesco; M Cortellaro; A Corradi; F Ravasi; F Bertocchi
Journal:  Thromb Haemost       Date:  1998-03       Impact factor: 5.249

6.  D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis.

Authors:  B Boneu; G Bes; H Pelzer; P Sié; H Boccalon
Journal:  Thromb Haemost       Date:  1991-01-23       Impact factor: 5.249

7.  D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism.

Authors:  Fredrik Wexels; Ingebjørg Seljeflot; Are H Pripp; Ola E Dahl
Journal:  Blood Coagul Fibrinolysis       Date:  2016-06       Impact factor: 1.276

8.  Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding events.

Authors:  L C Borris; M Breindahl; M R Lassen; A F Pap; F Misselwitz
Journal:  J Thromb Haemost       Date:  2008-08-01       Impact factor: 5.824

9.  Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin.

Authors:  H Arnesen; O E Dahl; T Aspelin; I Seljeflot; P Kierulf; T Lyberg
Journal:  J Thromb Haemost       Date:  2003-05       Impact factor: 5.824

Review 10.  Starting prophylaxis for venous thromboembolism postoperatively.

Authors:  C Kearon; J Hirsh
Journal:  Arch Intern Med       Date:  1995-02-27
View more
  1 in total

1.  An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow.

Authors:  Wei Yin; Andrew Dimatteo; Andrew Kumpfbeck; Stephen Leung; Marina Fandaros; Bryan Musmacker; David A Rubenstein; Mary D Frame
Journal:  Thromb J       Date:  2022-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.